According to Bumrungrad Hospital's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 32.5849. At the end of 2022 the company had a P/E ratio of 34.1.
Year | P/E ratio | Change |
---|---|---|
2022 | 34.1 | -63.08% |
2021 | 92.5 | 21.76% |
2020 | 75.9 | 165.56% |
2019 | 28.6 | -12.83% |
2018 | 32.8 | -6.09% |
2017 | 34.9 | -3.69% |
2016 | 36.3 | -18.86% |
2015 | 44.7 | 18.89% |
2014 | 37.6 | 55.35% |
2013 | 24.2 | 14.41% |
2012 | 21.2 | -1.28% |
2011 | 21.4 | 17.44% |
2010 | 18.2 | 5.77% |
2009 | 17.3 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.